2012
DOI: 10.1016/j.ejphar.2012.07.027
|View full text |Cite
|
Sign up to set email alerts
|

Changes of cytosolic calcium and contractility of young rat vas deferens by acute treatment with amphetamine, fluoxetine or sibutramine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
3
0

Year Published

2013
2013
2019
2019

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 40 publications
1
3
0
Order By: Relevance
“…Furthermore, sibutramine promotes increased tension developed in the epididymal duct, mediated by calcium ions influx, as shown by the nifedipine assays. This finding was corroborated by a previous work [37], in which sibutramine pretreatment promoted an influx of calcium ions and increased the tension developed in the vas deferens.…”
Section: Discussionsupporting
confidence: 87%
See 2 more Smart Citations
“…Furthermore, sibutramine promotes increased tension developed in the epididymal duct, mediated by calcium ions influx, as shown by the nifedipine assays. This finding was corroborated by a previous work [37], in which sibutramine pretreatment promoted an influx of calcium ions and increased the tension developed in the vas deferens.…”
Section: Discussionsupporting
confidence: 87%
“…Currently, there are some reports in the literature on the direct and indirect effects of sympathomimetic drugs on reproductive organs [12], [20], [34], [35], [36], [37], however there are no extensive studies on the mechanisms involved. In this study, we report pharmacological mechanisms by means sibutramine, a serotonin-NE reuptake inhibitor, promotes increased NE effects in the rat epididymal duct and ventral prostate and promotes NE depletion in the epididymis.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…This effect results in increased level of serotonin in the synaptic cleft, facilitating its binding to its postsynaptic receptor. However, in the past two decades, preclinical studies demonstrated that fluoxetine, and other SSRIs, also exert significant other cellular effects that are independent of their ability to inhibit serotonin reuptake and involve antagonism of serotonin receptors and inhibition of L-type and T-type voltage-dependent Ca 2+ channels, as well as other ion channels (Pacher et al, 1998; Pacher et al, 1999a; Ungvari et al, 1999; Deak et al, 2000; Pacher et al, 2000; Ungvari et al, 2000; Terstappen et al, 2003; Traboulsie et al, 2006; Jurkiewicz et al, 2012; Gobin et al, 2015). Importantly, fluoxetine, as well as other SSRIs, was shown to exert significant vascular effects, including inhibition of pressure-induced myogenic constriction of blood vessels (Pacher et al, 1999a; Ungvari et al, 1999; Ungvari et al, 2000) ( Figure 1 ).…”
Section: Vascular Side Effects Of Fluoxetine and Other Ssris: Potentimentioning
confidence: 99%